The pharmaceutical industry constantly seeks reliable sources for high-quality chemical intermediates to ensure the production of safe and effective medications. For manufacturers involved in synthesizing Erlotinib, a crucial drug for cancer treatment, Ethyl 3,4-Dihydroxybenzoate (CAS: 3943-89-3) is an indispensable component. This article highlights the importance of this intermediate and provides insights into sourcing it effectively from China.

Ethyl 3,4-Dihydroxybenzoate, also known as Ethyl Protocatechuate, is a key pharmaceutical intermediate with the molecular formula C9H10O4. Its chemical structure and purity, typically specified at ≥99%, are critical for its function in the synthesis of Erlotinib (CAS: 183321-74-6) and Erlotinib Hydrochloride (CAS: 183319-69-9). The physical characteristics, such as its appearance as a white crystalline powder, and its defined chemical properties, like its melting point range of 132-134 °C, are essential parameters that procurement specialists evaluate.

As a leading 'manufacturer and supplier of pharmaceutical intermediates in China', we understand the stringent requirements of the global pharmaceutical market. When you aim to 'buy Ethyl 3,4-Dihydroxybenzoate', partnering with a reputable entity ensures you receive material that meets rigorous quality control standards. The 'price of Ethyl 3,4-Dihydroxybenzoate' is a factor, but the assurance of purity and consistent supply is paramount for successful API manufacturing. We provide competitive pricing for bulk orders, catering to the needs of R&D laboratories and large-scale production facilities.

The application of Ethyl 3,4-Dihydroxybenzoate in the synthesis of Erlotinib is well-documented. Erlotinib, a tyrosine kinase inhibitor, has significantly impacted the treatment landscape for certain cancers. The efficiency and success of its synthesis are directly linked to the quality of the intermediates used. Therefore, identifying a reliable 'CAS 3943-89-3 supplier' that can guarantee product integrity and support regulatory documentation is vital for any pharmaceutical company.

For companies seeking to establish or maintain a stable supply chain, exploring 'pharmaceutical intermediate manufacturers' in China offers a strategic advantage. These manufacturers often possess advanced synthesis capabilities and adhere to international quality standards, making them ideal partners for critical raw materials. By choosing to procure from experienced suppliers, you can minimize risks associated with quality variations and supply disruptions.

In conclusion, Ethyl 3,4-Dihydroxybenzoate is more than just a chemical compound; it is a foundational element in the production of advanced cancer therapies. Prioritizing a high-purity product from a trusted 'China manufacturer' for this intermediate is a critical step for any pharmaceutical company aiming for quality and efficiency in their Erlotinib production. We are committed to being that trusted supplier, supporting your critical needs with excellence.